Filter Results:
(328)
Show Results For
- All HBS Web (328)
- Faculty Publications (138)
Show Results For
- All HBS Web (328)
- Faculty Publications (138)
- 28 Aug 2017
- Research & Ideas
Should Industry Competitors Cooperate More to Solve World Problems?
example here. More business leaders in the health care sector recognize that industry actors that engage in egregious pricing of drugs bring all kinds of problems to the whole industry. Silverthorne: You note that companies by themselves... View Details
- 24 May 2011
- First Look
First Look: May 24
decade. The small venture that he had started with a few of his scientist colleagues in the late 1990s to discover novel medicine in a research-driven organisation had grown into one of Europe's largest biotech firms by revenues. Their success was mainly founded on... View Details
Keywords: Sean Silverthorne
- 03 Mar 2009
- First Look
First Look: March 3, 2009
pharmaceutical division and a diagnostic division. The company's antiviral drug Tamiflu dominates the market for prevention and treatment of seasonal influenza (flu). Tamiflu, however, could also play an... View Details
Keywords: Martha Lagace
- 03 Oct 2006
- First Look
First Look: October 3, 2006
considering selling its royalty interest in Enbrel, Amgen's blockbuster drug for the treatment of rheumatoid arthritis. In assessing whether to sell, and at what price, the hospital must determine its value... View Details
Keywords: Sean Silverthorne
- 03 Jan 2017
- First Look
January 3, 2017
to standardize their products and helped establish brand identities through consistent appearance. By 1938, food dyes had achieved such widespread use, and had raised such public concern, that the federal government amended the 1906 Pure Food and View Details
Keywords: Carmen Nobel
- 13 Sep 2011
- First Look
First Look: September 13
come primarily from the non-drug treatment (87.4% and 70.2% respectively), whereas gains from detailing come at the expense of competing drugs (84%). By contrast, the random coefficient logit model predicts... View Details
Keywords: Sean Silverthorne
- 06 Jun 2017
- First Look
First Look at New Research and Ideas: June 6, 2017
Pharmacyclics is a biotechnology company that had received FDA approval in late 2013 for its flagship asset Imbrivica (ibrutinib), a biologic treatment for chronic lymphocytic leukemia and two other even rarer blood malignancies. Entering... View Details
Keywords: Sean Silverthorne
- Web
Winners & Success Stories | New Venture Competition
Pharmaceuticals Alec Machiels, MBA 2001 Potentia is a clinical-stage biotechnology company with a world-class scientific team and scientific advisory board. The company’s mission is to bring the first treatment targeting the root cause of... View Details
- 04 Feb 2014
- First Look
First Look: February 4
Course overview of The Entrepreneurial Manager. Purchase this case: http://hbr.org/product/the-entrepreneurial-manager-course-overview-2014-winter-term-course-overview-note/an/814064-PDF-ENG Harvard Business School Case 814-003 FasterCures: Removing Barriers to View Details
Keywords: Sean Silverthlorne
- 15 Apr 2008
- First Look
First Look: April 15, 2008
nationally recognized practicing psychiatrist who has developed outpatient treatment programs based on Dialectical Behavior Therapy (DBT) for patients with borderline personality disorder (BPD). These patients, typically adolescent girls... View Details
Keywords: Martha Lagace
- 19 Mar 2015
- News
Walter Salmon Remembered
received a similar treatment from our section. That show of affection indicated that many of my section mates felt as I did about the impact he had on our thinking about the subject of marketing. You will be missed, Professor Salmon.... View Details
- 21 Aug 2018
- First Look
New Research and Ideas, August 21, 2018
information in online retail. In our experiments, customers are randomly assigned to a treatment condition where virtual fit information is available or to a control condition where virtual fit information is not available. Our results... View Details
Keywords: Dina Gerdeman
- 01 Dec 2008
- News
Business at the Summit
Gates said, does many things well, but the inspiration for the Bill & Melinda Gates Foundation came in part from a market failure in health-care delivery. Individuals who live in areas where tuberculosis, AIDS, and malaria are still common are often too poor to afford... View Details
- 24 Jun 2014
- First Look
First Look: June 24
http://hbr.org/product/mobile-broadband-and-the-telecommunications-industry-in-2011/an/814009-PDF-ENG Harvard Business School Case 314-103 The Novartis Malaria Initiative The Novartis Malaria Initiative was designed, as a result of a precedent-setting agreement with... View Details
Keywords: Sean Silverthorne
- 15 Dec 2015
- News
The Year in Ideas 2015
to something big. After a second field study, Solomon and Hillerstrom launched NeuroPhage. In tests on mice, the drug they developed improved both memory and cognitive abilities. “We believe it can identify harmful aggregates in the... View Details
- 12 May 2009
- First Look
First Look: May 12, 2009
Sermo, Inc. Harvard Business School Case 809-142 Sermo operates the leading online professional network for physicians in the United States. Doctors use Sermo free of charge to post surveys regarding diagnostic and treatment concerns and... View Details
Keywords: Martha Lagace
- 24 Jul 2007
- First Look
First Look: July 24, 2007
the formation and rapid growth of a drug-testing company. The company needs to decide whether to enter the painkiller testing market, in addition to growing its drug treatment center business. Purchase this... View Details
Keywords: Martha Lagace
- 12 Feb 2008
- First Look
First Look: February 12, 2007
stake of 9.5% in Ligand Pharmaceuticals, Inc., a specialty pharmaceutical company. Third Point believed that Ligand had a strong drug portfolio and pipeline but that it was highly undervalued due to poor management. After gaining board... View Details
Keywords: Martha Lagace
- 01 Sep 2018
- News
September 2018 Alumni and Faculty Books
Forsythe stories feature a talented African American man, wrongfully imprisoned, who becomes a successful drug lord. The Carmichael stories feature two generations of Swedish immigrants in upstate New York, facing—or avoiding—the... View Details